Related Experiment Video
Updated: Aug 10, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Regression of cellular hypertrophy after left ventricular assist device support
A Zafeiridis1, V Jeevanandam, S R Houser
1Department of Internal Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Left ventricular assist device (LVAD) therapy reverses cardiac remodeling by reducing myocyte size and improving heart shape. This cellular change contributes to improved mechanical performance and reduced wall stress after LVAD implantation.
Area of Science:
- Cardiology
- Biomedical Engineering
- Heart Failure Research
Background:
- Left ventricular assist device (LVAD) therapy is known to improve cardiac geometry.
- The underlying pathological mechanisms driving this
- reverse remodeling
- remain unclear.
- Understanding cellular changes is crucial for optimizing LVAD therapy.
Purpose of the Study:
- To investigate the effects of LVAD support on cardiac myocyte size and shape.
- To elucidate the cellular mechanisms of reverse remodeling in the failing heart.
Main Methods:
- Cardiac myocytes were isolated from explanted hearts of patients with heart failure (with and without LVAD support) and from nonfailing hearts.
- Myocyte dimensions (volume, length, width, thickness) were quantified using validated techniques.
- Echocardiography was used to assess left ventricular dimensions and mass in LVAD patients.
Main Results:
- Myocytes from failing hearts showed increased volume, length, width, and length-to-thickness ratio compared to normal myocytes.
- Long-term LVAD support significantly reduced myocyte volume (28%), length (20%), width (20%), and length-to-thickness ratio (32%).
- LVAD support did not alter myocyte thickness but was associated with reduced left ventricular dilation and mass.
Conclusions:
- Regression of cellular hypertrophy is a key mechanism in LVAD-induced reverse remodeling.
- Parallel changes at the organ and cellular levels contribute to reduced wall stress.
- LVAD therapy promotes favorable geometric alterations, potentially improving cardiac mechanical performance.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cellular Adaptation II: Hypertrophy

